dilapan

01/01/2021 - "The lack of difference in pain between laminaria and Dilapan-S enhances the applicability of pain intervention research across dilator types. "
01/01/2021 - "Median pain increase did not differ in participants receiving laminaria or Dilapan-S for cervical preparation prior to D&E. "
01/01/2021 - "Maximum median pain was not statistically different (Laminaria: +3.5 (interquartile range [IQR] +0.5, +6.5); Dilapan-S: +3 (IQR +1, +5); p = 0.42. "
01/01/2021 - "To compare pain levels and medication needs after placement of laminaria vs Dilapan-S, and after dilation and evacuation (D&E). "
04/01/2000 - "Physical pain remained one of the main concerns for patients given Dilapan. "

11/10/2015 - "Mechanical (Dilapan-S hygroscopic) dilators performed similarly to chemical dilators in a single trial (65 women) that measured difficulty in cervical dilation, excessive bleeding and adverse effects.Misoprostol"

09/01/2021 - "Our study included 74 patients with a second-trimester antenatal death who were randomized into two groups to receive pharmacological induction of miscarriage combined with intracervical insertion of dilapan-S (n = 37) or pharmacological induction of miscarriage only (n = 37). "
09/01/2021 - "Combined management of antenatal pregnancy loss in the second trimester including intracervical insertion of dilapan-S and conventional induction with miscarriage may be considered a valuable clinical strategy. "
09/01/2021 - "The aim of this study was to assess the outcomes of combined use of dilapan-S and pharmacological induction of miscarriage with mifepristone and misoprostol versus mifepristone and misoprostol only in patients with a second-trimester pregnancy loss. "
09/01/2021 - "The use of dilapan-S together with mifepristone and misoprostol for induction of miscarriage in the second trimester in women with antenatal fetal death reduced the time from the start of the procedure to complete miscarriage by 1.98-fold. "

04/01/1997 - "There was one neonatal death and one case of neonatal sepsis in the Dilapan group. "

06/01/1989 - " The synthetic Dilapan tent does not share the disadvantages of inconsistency, long duration of action, and risk of sepsis, but tends to fragment and fracture so that the distal portion remains within the uterus. "